Vaccine
-
Review
Success stories in the implementation of universal hepatitis B vaccination: an update on Italy.
Compulsory universal vaccination against hepatitis B was introduced in 1991 in Italy for all newborns and 12-year-olds. Despite the decreasing circulation of the virus noted in the late-1980s, it was clear that only universal immunization would control hepatitis B infection and limit the transmission of the virus. ⋯ Since 1995, the decrease in acute cases of hepatitis B has accelerated in the age groups 0-14 and 15-24, particularly in two regions of the north; during the same period, no comparable decrease in incidence was seen in older age groups. Monitoring coverage of vaccination and incidence of acute disease and seroepidemiological studies will continue and should show a rapid progression towards the elimination of HBV circulation in the country.
-
Clinical Trial
Opportunities not missed--systematic influenza and pneumococcal immunization in a public inner-city emergency department.
To demonstrate the feasibility of systematic influenza and pneumococcal vaccination in a busy Emergency Department (ED). ⋯ Systematic ED immunization of high-risk adults is feasible even in a busy public ED setting.
-
The most menacing complication of herpes zoster in immunocompetent elderly people is chronic pain or postherpetic neuralgia (PHN). The cardinal epidemiological feature of PHN is its striking relationship to aging. Among zoster patients over 60 years old, estimates of the occurrence of PHN, defined as pain 1 month after rash onset, vary from 27 to 68%. ⋯ The outcomes of this pain include fatigue, sleep disturbance, anorexia, depression, social withdrawal, impaired activities of daily living and profound lowering of quality of life. The management of PHN is hampered by two problems: (1) a uniformly effective treatment for PHN is not available (although tricyclic antidepressants, local or regional anaesthetics, capsaicin, opiates, anticonvulsants and physical therapies are sometimes useful); and (2) early antiviral therapy of zoster may be ineffective in preventing PHN, partly related to the fact that days of VZV replication and neuronal destruction have occurred by the time the patient reaches the doctor. A potential solution to the problem of PHN is the vaccination of elderly persons with the varicella vaccine to prevent or attenuate zoster or PHN.
-
The objectives of surveillance for vaccine preventable disease vary with the stage of the vaccination programme. Pre-implementation data is required to estimate the burden of disease and to decide on the appropriate vaccination strategy. Post-implementation data is required to monitor effectiveness but when high coverage is achieved surveillance must be able to accurately identify remaining pockets of susceptible persons. ⋯ Where the incidence is low, however, this approach, will be very expensive. Surveillance of vaccine preventable disease therefore requires flexible surveillance systems which are able to adapt to changes in incidence of infection and in control policy. The use of multiple data sources and supportive information from special studies is essential for the valid interpretation of routine data.